FDA Brief

Company record

ONESOURCE SPECIALTY PHARMA LIMITED

0 FDA warning letters since 2023 and 1 recall in the last 12 months.

Get an email the day FDA posts anything new about ONESOURCE SPECIALTY PHARMA LIMITED.

Recalls

ReportedClassFirmProduct and reason
Jul 15 Class II ONESOURCE SPECIALTY PHARMA LIMITED
Drug
Methohexital Sodium for Injection, USP 500 mg Multiple Dose Vial, Rx Only, Manufactured by: OneSource Specialty, Pharma Limited, Bengaluru - 561 203, India, Manufactured for: Avet Pharmaceuticals Inc., East Brunswick, NJ…
Failed Impurities/Degradation Specifications